Income Statement
TEVOGEN BIO HOLDINGS INC.
TVGN
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
26.14 | 53.56 | 2.27 | 0.95 | 0.00 |
|
Research & Development
|
11.11 | 31.03 | - | - | - |
|
Selling, General & Administrative
|
15.03 | 22.53 | 2.27 | 0.95 | - |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-26.14 | -53.56 | -2.27 | -0.95 | - |
|
Non-Operating Income
|
- | - | 2.21 | 5.36 | - |
|
Interest Income
|
- | - | 2.73 | 4.95 | - |
|
Interest Expense
|
- | 0.18 | 0.26 | - | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - |
|
Income Before Tax
|
- | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-26.28 | -13.73 | -0.07 | 4.41 | - |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-26.14 | -53.56 | -2.27 | -0.95 | 0.00 |
|
Earnings Per Share (Basic)
|
-8.08 | -0.07 | 0.00 | 0.09 | - |
|
Diluted EPS
|
-8.08 | -0.07 | 0.00 | 0.09 | - |
|
Weighted Average Shares
|
3.32 | 146.67 | 12.32 | 35.95 | - |
|
Diluted Weighted Avg Shares
|
3.32 | 146.67 | 12.32 | 35.95 | - |
|
Comprehensive Income
|
- | - | - | - | - |